Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Stolk

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Respiratory Research|June 2, 2005
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiencyJan Stolk, Barbara Veldhuisen, Laura Annovazzi, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 11, 2019
TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formationJohn-Poul Ng-Blichfeldt, Tristan de Jong, Rosa K Kortekaas, et al.
Radiology|April 20, 2011
Eureka?Berend C Stoel, Asger Dirksen, Robert A Stockley, et al.
Journal of Thoracic Imaging|May 27, 2017
Lung Density and Pulmonary Artery Diameter are Predictors of Pulmonary Hypertension in Systemic SclerosisMargreet E Bakker, Maarten K Ninaber, Jan Stolk, et al.
Plos One|June 13, 2015
Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?Yvonne Nussbaumer-Ochsner, Jan Stolk, Luiz F Ferraz da Silva, et al.
The European Respiratory Journal|August 31, 2019
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPDJan Stolk, Naveh Tov, Kenneth R Chapman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 9, 2022
Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip culturesSander van Riet, Annemarie van Schadewijk, P Padmini S J Khedoe, et al.
ERJ Open Research|August 26, 2021
Long-term effect of α<sub>1</sub>-antitrypsin augmentation therapy on the decline of FEV<sub>1</sub> in deficient patients: an analysis of the AIR databaseIris G M Schouten, Marise J Kasteleyn, Roula Tsonaka, et al.
American Journal of Respiratory and Critical Care Medicine|June 3, 2004
Dissociation of lung function and airway inflammation in chronic obstructive pulmonary diseaseThérèse S Lapperre, Jiska B Snoeck-Stroband, Margot M E Gosman, et al.
Journal of Hepatology|March 25, 2018
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patientsAlice M Turner, Jan Stolk, Robert Bals, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Respiratory Research|June 2, 2005
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiencyJan Stolk, Barbara Veldhuisen, Laura Annovazzi, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 11, 2019
TGF-β activation impairs fibroblast ability to support adult lung epithelial progenitor cell organoid formationJohn-Poul Ng-Blichfeldt, Tristan de Jong, Rosa K Kortekaas, et al.
Radiology|April 20, 2011
Eureka?Berend C Stoel, Asger Dirksen, Robert A Stockley, et al.
Journal of Thoracic Imaging|May 27, 2017
Lung Density and Pulmonary Artery Diameter are Predictors of Pulmonary Hypertension in Systemic SclerosisMargreet E Bakker, Maarten K Ninaber, Jan Stolk, et al.
Plos One|June 13, 2015
Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?Yvonne Nussbaumer-Ochsner, Jan Stolk, Luiz F Ferraz da Silva, et al.
The European Respiratory Journal|August 31, 2019
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPDJan Stolk, Naveh Tov, Kenneth R Chapman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 9, 2022
Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip culturesSander van Riet, Annemarie van Schadewijk, P Padmini S J Khedoe, et al.
ERJ Open Research|August 26, 2021
Long-term effect of α<sub>1</sub>-antitrypsin augmentation therapy on the decline of FEV<sub>1</sub> in deficient patients: an analysis of the AIR databaseIris G M Schouten, Marise J Kasteleyn, Roula Tsonaka, et al.
American Journal of Respiratory and Critical Care Medicine|June 3, 2004
Dissociation of lung function and airway inflammation in chronic obstructive pulmonary diseaseThérèse S Lapperre, Jiska B Snoeck-Stroband, Margot M E Gosman, et al.
Journal of Hepatology|March 25, 2018
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patientsAlice M Turner, Jan Stolk, Robert Bals, et al.
Pageof 11